Boston Scientific Corporation logo

Boston Scientific Corporation BSX

$ 90.35 0.02%

Quarterly report 2024-Q3
added 11-01-2024

report update icon

Country

usaUSA

IPO year

-

Industry

Medical devices

Stock Exchange

NYSESPB

CEO

Mr. Michael Mahoney

Employees in the company

36 000

Shares

1.45 B

Market Cap[1]

$ 131 B

EBITDA (LTM)

$ 3.22 B

P/E (LTM)

68.54

P/S (LTM)

7.73

EPS (LTM)

1.22

Boston Scientific is an international company that specializes in the development and manufacturing of medical devices and technologies for the treatment of various diseases. It was founded in 1979 in the United States and is now one of the largest medical device manufacturers in the world.

Boston Scientific offers a wide range of medical devices, including stents, cardiac pacemakers, defibrillators, electrodes, urological and gynecological devices, and much more. It also provides physician training, consultation, and patient support services.

The company has offices around the world and serves patients in over 100 countries. Its headquarters are located in Massachusetts, USA.

The goal of Boston Scientific is to help people live healthy lives by providing them with innovative medical devices and technologies. The company actively works on developing new products and improving the quality of its services to meet the needs of its customers.

Other stocks of industry "Medical devices"

Issuer Price % 24h Market Cap Exchange Country
Natus Medical Incorporated Natus Medical Incorporated
NTUS
$ 31.08 1.94 % $ 1.05 B Nasdaq Global Select Market,SPB usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
$ 9.22 24.59 % $ 44.8 M Nasdaq Global Select Market chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
$ 3.05 -5.86 % $ 30.6 M Nasdaq Capital Market usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
$ 0.24 14.99 % $ 929 K Nasdaq Capital Market usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
$ 20.0 0.15 % $ 844 M Nasdaq Global Select Market,SPB usaUSA
Neovasc Neovasc
NVCN
$ 30.03 - $ 111 M Nasdaq Capital Market canadaCanada
Apollo Endosurgery Apollo Endosurgery
APEN
$ 10.0 - $ 475 M Nasdaq Global Market usaUSA
Titan Medical Titan Medical
TMDI
$ 0.14 -26.32 % $ 19.6 M Nasdaq Global Select Market canadaCanada
FONAR Corporation FONAR Corporation
FONR
$ 14.79 0.22 % $ 96.9 M Nasdaq Capital Market usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 22.8 -0.35 % $ 1.83 B Nasdaq Global Select Market,SPB usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 41.22 9.85 % $ 1.06 B Nasdaq Capital Market costa-ricaCosta-rica
Viveve Medical Viveve Medical
VIVE
$ 0.22 -15.35 % $ 1.71 M Nasdaq Global Select Market usaUSA
Invacare Corporation Invacare Corporation
IVC
$ 0.66 - $ 24.7 M NYSE usaUSA
Abiomed Abiomed
ABMD
$ 381.02 - $ 17.2 B Nasdaq Global Select Market,SPB usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
$ 0.55 3.58 % $ 2.21 M Nasdaq Capital Market usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 84.0 -1.18 % $ 112 B NYSE,SPB usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
$ 5.28 1.15 % $ 34.5 M Nasdaq Capital Market usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
$ 17.84 -4.14 % $ 702 M NYSE,SPB usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
$ 24.04 - $ 1.77 B Nasdaq Global Select Market usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
$ 20.12 -1.42 % $ 435 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.